Diabetes Mellitus Type 2 in Obese Clinical Trial
Official title:
Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery
Describe and characterize the time-course for improvement in glucose control after bariatric
surgery in obese patients with type 2 diabetes
Compare these changes in glycemic control after different techniques for bariatric surgery
Obesity and its ensuing metabolic complications such as type 2 diabetes mellitus, are
exponentially increasing worldwide. * * The most effective treatment for obesity is bariatric
surgery. * Different bariatric procedures are available. In the 1960's, the Roux-en-Y gastric
bypass (RYGB) was developed, in which the stomach is divided with staplers to create a small
gastric pouch, while the jejunum is divided 30 to 50 cm distal to the ligament of Treitz. The
distal limb is then anastomosed to the small gastric pouch and a jejunojejunostomy is
performed 50 to 150 cm distal from the gastrojejunostomy. Sleeve gastrectomy on the other
hand, reduces the stomach size by vertical stapling. In the 1990's, gastric banding was
developed, reducing the volume of the stomach by annular banding. The amount of excess body
weight reduction varies among the different techniques, with 60% to 70% reported for RYGB*,
55% for sleeve gastrectomy* and up to 65% for gastric banding*. Worldwide, it is estimated
that a total of 344000 procedures were performed in 2008. Roux-en-Y gastric bypass was the
most common (47%) followed by gastric banding (42%) and sleeve gastrectomy (5%).*
In 1987, Pories et al. published data on the stunning observation that 99% of obese patients
with type 2 diabetes or impaired glucose tolerance that had undergone Roux-en-Y gastric
bypass became and remained euglycemic after surgery.* Since then, all commonly used bariatric
procedures have been shown to restore a normal glucose profile in many diabetes patients.
Current data suggest that the bypass procedures are more effective in doing so, with success
rates up to 80%,* than the purely restrictive procedures such as sleeve gastrectomy and
gastric banding, with success rates varying between 30% and 70%.* The improvement in
glycaemic control is already seen a few days after surgery, long before any substantial
weight loss occurs.
Although different reasons for the rapid amelioration in glycaemic control are discussed in
literature, the exact underlying mechanisms are still not understood. In the restrictive
procedures, the effect is thought to be mainly mediated by caloric restriction and the
ensuing reduction in body weight and improvement in insulin resistance.* The malabsorptive
procedures, such as RYGB, offer different explanatory possibilities. In the so-called
'fore-gut hypothesis', it is suggested that the exclusion of the duodenum and proximal
jejunum may reduce insulin resistance. * The 'hind-gut hypothesis' on the other hand,
suggests that it is the altered delivery of nutrients to the distal small bowel that causes
exaggerated responses of the gut hormones. These gut hormones act as anorectic agents and as
incretins that stimulate the beta cells in the pancreas to restore normal first phase insulin
response. *
Most studies to investigate the alterations in glucose metabolism are performed weeks to
months after surgery. There are limited data on the evolution of blood glucose in the first
days and weeks after RYGB.* However, to our knowledge, no such data exist on the glycaemic
control immediately after sleeve gastrectomy and gastric banding. With the present study we
document the evolution in glycaemic control immediately after RYGB, sleeve gastrectomy and
gastric banding in type 2 diabetic subjects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02668328 -
Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients
|
N/A | |
Recruiting |
NCT05942079 -
"The Effect of Reiki on Metabolic Parameters in Obese Type 2 Diabetes Patients''
|
||
Not yet recruiting |
NCT06333132 -
Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat)
|
N/A | |
Active, not recruiting |
NCT05579561 -
Vegetarian Ketogenic Diet VS Omnivore Ketogenic Diet - Protocol of a Keto-vege Diet for Remission of Type 2 Diabetes
|
N/A | |
Completed |
NCT02938026 -
Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle Counselling
|
N/A | |
Recruiting |
NCT05887271 -
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
Completed |
NCT02680873 -
Efficacy of SASI Bypass for Type-2 Diabetic Obese Patients
|
N/A | |
Completed |
NCT01364350 -
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
|
||
Not yet recruiting |
NCT05711043 -
The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
|
N/A | |
Completed |
NCT02784275 -
A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT01874366 -
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
|
Phase 1 | |
Recruiting |
NCT03821636 -
Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.
|
N/A | |
Recruiting |
NCT03904901 -
Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight
|
N/A | |
Active, not recruiting |
NCT01989988 -
DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM
|
N/A | |
Completed |
NCT02122874 -
Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients
|
Phase 3 | |
Completed |
NCT03394157 -
Randomized Comparative Study of Sleeve Gastrectomy Versus MGB and SASI Bypass , Randomized Study
|
N/A | |
Recruiting |
NCT04227769 -
IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
|
Phase 2 | |
Active, not recruiting |
NCT05755321 -
From Skin Fibroblasts to Neural Stem Cells to Investigate in Vitro the Impact of Diabetes on Adult Neurogenesis
|
||
Completed |
NCT04957589 -
VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men
|
N/A | |
Recruiting |
NCT05801614 -
Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction
|
N/A |